Related Experiment Video
Updated: Jul 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Descriptive study of vascular complications secondary to antithrombotic agents and percutaneous cardiovascular
Ana Rosa Alconero Camarero1, María Casáus Pérez, Luz Elena Mirones Valdeolivas
1Escuela Universitaria de Enfermería Casa de Salud Valdecilla, Universidad de Cantabria, Santander, España. alconear@unican.es
Insights
Vascular complications like hematomas and femoral bleeding occur in 39% of patients receiving antithrombotic drugs and percutaneous transluminal coronary angioplasty (PTCA). Arterial sheath duration is a key factor contributing to these bleeding events.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Antithrombotic drugs significantly reduce morbidity and mortality in acute coronary syndrome patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
- However, these vital medications increase the risk of bleeding complications following interventional procedures.
Purpose of the Study:
- To determine the incidence of vascular complications in patients treated with antithrombotic drugs and percutaneous cardiovascular interventions.
- To identify variables associated with the occurrence of these vascular complications.
Main Methods:
- A retrospective descriptive study analyzed clinical histories of 153 patients.
- Patients underwent primary angioplasty or rescue treatment between October 2001 and October 2002.
- Data included patient demographics, diagnoses (75% acute myocardial infarction), procedure types (71% primary angioplasty), antithrombotic drug use, compression methods, and arterial sheath duration.
Main Results:
- Vascular complications occurred in 39% of patients.
- Hematomas were the most frequent complication (28%), followed by femoral bleeding.
- Increased arterial sheath duration was identified as a significant contributing factor to vascular complications.
Conclusions:
- Combining antithrombotic drugs with PTCA leads to vascular complications in approximately one-third of patients.
- Hematomas and femoral bleeding are the predominant complications.
- Arterial sheath management, specifically its duration, is crucial for minimizing vascular complication risk.
Abstract:
Administration of drugs in the patients diagnosed of acute coronary syndrome and treated with percutaneous transluminal coronary angioplasty (PTCA) has noticeably reduced morbidity-mortality and appearance of new ischemic events. However, these drug agents may cause bleeding problems secondary to therapeutic intervention. The objectives of this research are: to know the incidence of vascular complications developed in patients treated with antithrombotic drugs and percutaneous cardiovascular interventionism and describe variables that may be related with their appearance. A retrospective descriptive study was done on the registries of the clinical histories of 153 patients subjected to primary angioplasty and rescue treatment during the period ranging from October 1, 2001 to October 31, 2002 in the Hospital Universitario Marques de Valdecilla. Mean age of the patients was 63 years, 75% diagnosed of acute myocardial infarction and 71% subjected to primary angioplasty. Drugs used were anticoagulants, antiaggregants and fibrinolytics. Furthermore compression methods and arterial sheath duration time were analyzed. Complications appeared in 39% of the patients, the most frequent complication being the hematoma in 28%. It is concluded that when antithrombotic drugs are combined with PTCA, vascular complications appear in one third of the patients studied, the appearance of hematomas standing out in the first place and in the second place, femoral bleeding. The main study variables also contributing to their appearance are the permanence of the sheath and its removal.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies